MedTrace Logo

Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study

NCT01455610 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2011-10-20

No results posted yet for this study

Summary

The purpose of this multicenter and double-blind clinical trial is to prospectively assess the sensitivity, specificity, negative predictive value, positive predictive value, and accuracy in respectability of pancreatic head cancer with contrasted-enhanced MDCT and its various post processing techniques, taking operational and pathological records as the gold standard.

Conditions

  • Adenocarcinoma of Head of Pancreas

Sponsors & Collaborators

  • Changhai Hospital

    collaborator OTHER

  • Shanghai Cancer Hospital, China

    collaborator OTHER

  • Ruijin Hospital

    collaborator OTHER

  • Huashan Hospital

    collaborator OTHER

  • Huadong Hospital

    collaborator OTHER

  • Meng Su Zeng

    lead OTHER

Principal Investigators

  • Mengsu Zeng, MD, PhD · Radiology Department, Zhongshan Hospital of Fudan University

  • Jianping Lu, MD,PhD · Radiology Department, Changhai Hospital Affiliated to Second Military Medical University

  • Weijun Peng, MD, PhD · Radiology Department, Cancer Hospital Affiliated to Fudan University

  • Fuhua Yan, MD, PhD · Radiology Department, Ruijin Hospital Affiliated to Shanghai Jiaotong University, China

  • Xiaoyuan Feng, MD, PhD · Radiology Department, Huashan Hospital, Fudan University, China

  • Yanqing Hua, MD, PhD · Radiology Department, Huadong Hospital Affiliated to Fudan University, China

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01455610 on ClinicalTrials.gov